Suzon, Bienvenida Q.

HRN: 19-81-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2022
CEFTRIAXONE 1G (VIAL)
05/20/2022
05/26/2022
IV
2g
OD
CAP MR
Waiting Final Action 
05/20/2022
AZITHROMYCIN 500MG TABLET (TAB)
05/20/2022
05/24/2022
PO
500mg
Once Daily
CAP MR
Waiting Final Action 
06/14/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/14/2022
06/20/2022
IV
1.5
Q6
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: